Matches in Wikidata for { <http://www.wikidata.org/entity/Q59383532> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q59383532 description "artikull shkencor i botuar më 01 shkurt 2009" @default.
- Q59383532 description "artículu científicu espublizáu en febreru de 2009" @default.
- Q59383532 description "bài báo khoa học" @default.
- Q59383532 description "im Februar 2009 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59383532 description "scientific article published on 01 February 2009" @default.
- Q59383532 description "wetenschappelijk artikel" @default.
- Q59383532 description "наукова стаття, опублікована в грудні 2008" @default.
- Q59383532 name "Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety" @default.
- Q59383532 name "Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety" @default.
- Q59383532 name "Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety" @default.
- Q59383532 type Item @default.
- Q59383532 label "Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety" @default.
- Q59383532 label "Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety" @default.
- Q59383532 label "Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety" @default.
- Q59383532 prefLabel "Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety" @default.
- Q59383532 prefLabel "Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety" @default.
- Q59383532 prefLabel "Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety" @default.
- Q59383532 P1433 Q59383532-76893914-8DCD-4DC6-B2E0-56AFD7990FF4 @default.
- Q59383532 P1476 Q59383532-2DC34BD0-CC84-45DB-9C08-FB795E6E29BB @default.
- Q59383532 P2093 Q59383532-5363377A-5BA0-4232-BD37-81AE86D430ED @default.
- Q59383532 P304 Q59383532-D05F2ACA-7DA6-433B-B141-AB6FBF65933C @default.
- Q59383532 P31 Q59383532-7C2D6637-536F-43D9-A685-E7650110D0DD @default.
- Q59383532 P31 Q59383532-9f2211fe-4205-4650-9f95-12da280379d3 @default.
- Q59383532 P356 Q59383532-D120F1DE-6BAD-47CC-A49B-228FD3CAB161 @default.
- Q59383532 P407 Q59383532-DB7562B6-05A3-498A-8138-A3A57A905BF0 @default.
- Q59383532 P433 Q59383532-51B0D207-410A-42D0-83C3-AF4FDDE8097C @default.
- Q59383532 P478 Q59383532-28EFDB8D-2988-4778-8F7B-280F6BBD3434 @default.
- Q59383532 P577 Q59383532-3C01AAFF-F431-475A-A87A-6FEFDDAF5224 @default.
- Q59383532 P698 Q59383532-01ABFD35-850F-46D1-8645-16C35408F946 @default.
- Q59383532 P921 Q59383532-2BF066AA-1DDC-4AED-A40A-9959439295A7 @default.
- Q59383532 P356 14712590802658428 @default.
- Q59383532 P698 19236256 @default.
- Q59383532 P1433 Q5421201 @default.
- Q59383532 P1476 "Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety" @default.
- Q59383532 P2093 "Michael Beck" @default.
- Q59383532 P304 "255-261" @default.
- Q59383532 P31 Q13442814 @default.
- Q59383532 P31 Q7318358 @default.
- Q59383532 P356 "10.1517/14712590802658428" @default.
- Q59383532 P407 Q1860 @default.
- Q59383532 P433 "2" @default.
- Q59383532 P478 "9" @default.
- Q59383532 P577 "2009-02-01T00:00:00Z" @default.
- Q59383532 P698 "19236256" @default.
- Q59383532 P921 Q615645 @default.